Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cells Derived from Amniotic Fluid no Substitute for Embryonic Cells

Published: Wednesday, January 10, 2007
Last Updated: Wednesday, January 10, 2007
Bookmark and Share
The GPI welcomes the discovery of versatile stem cells in amniotic fluid as a positive development while cautioning that it does not eliminate the need for embryonic stem cell research.

The Genetics Policy Institute (GPI) applauds the discovery of apparently versatile stem cells in amniotic fluid as a positive development, but cautions that the research does not eliminate the need for embryonic stem cell research.

"This discovery is a welcome development that opens up a new line of research," said Eve Herold, who is GPI's director of public policy research and education and also the author of the recent book, Stem Cell Wars: Inside Stories from the Frontlines. "However, much more work needs to be done before anyone can determine the cells' future clinical value."

Over the weekend, a team of scientists led by Anthony Atala at Wake Forest University School of Medicine announced that it had cultured what appeared to be highly versatile stem cells, which were taken from the amniotic fluid of women who were about ten weeks pregnant.

Stem cell researcher Dr. Larry Goldstein, whose work at the University of California-San Diego focuses on neurons derived from embryonic stem cells, noted that the Wake Forest team had culled cells that appeared to be neurons.

However, he said "Based on what they have published, the (amniotic fluid- derived) cells don't seem to make neurons as usable as what we routinely make with human embryonic stem cells. But perhaps with further work, their cells and methods will improve."

"People have been excited about new cell types in the past and were later disappointed," Herold cautioned.

"Science is a slow process. Experiments need to be repeated and independently verified before they become established as facts. However, this line of research should definitely be pursued along with all other types of stem cell research. This early report does not suggest that we should abandon the science that has been proven over and over again to be so promising."

"There is only one 'card carrying' pluripotent human embryonic stem cell. Patients demanding cures must reject any attempted spin on this story claiming the work with fetal cells is an actual alternative to current embryonic stem cell research,” said Bernard Siegel, executive director of the Genetics Policy Institute.

“Most scientists believe that different types of stem cells will eventually be needed to treat different diseases. For this entire field to advance, the current federal restrictions on funding must be lifted now," he continued.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

World Stem Cell Report to be Published in Regenerative Medicine
The Genetics Policy Institute (GPI) and Future Medicine have announced that its 2011/12 World Stem Cell Report will be published as a special supplement to the award-winning, peer-reviewed journal Regenerative Medicine.
Thursday, April 14, 2011
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Mutated Mitochondria Found in Stem Cells
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!